Lucid Diagnostics Inc. announced the publication of a Future Effective Local Coverage Determination on molecular testing for esophageal precancer and cancer in Medicare beneficiaries.
AI Assistant
LUCID DIAGNOSTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.